Information Provided By:
Fly News Breaks for May 12, 2017
EGLT
May 12, 2017 | 09:00 EDT
Gabelli analyst Kevin Kedra upgraded Egalet to Buy from Hold with a 2018 PMV of $9.50 saying shares are oversold following Arymo approval. The analyst said Arymo is off to a slow start but said potential managed care wins and approval of abuse deterrence labeling for Oxaydo could prove to be near-term catalysts. Longer-term, Kedra said Egalet is well positioned to benefit from the shift away from older opiods without abuse deterrence features.
News For EGLT From the Last 2 Days
There are no results for your query EGLT